Q0175
HCPCSPerphenazine 4mg oral
Official HCPCS Level II long descriptor
Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Level II code Q0175 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Perphenazine 4mg oral
Added to HCPCS: 1998-04-01
Nearby codes in Q0
- Q0161Chlorpromazine hcl 5mg oral
- Q0162Ondansetron oral
- Q0163Diphenhydramine hcl 50mg
- Q0164Prochlorperazine maleate 5mg
- Q0166Granisetron hcl 1 mg oral
- Q0167Dronabinol 2.5mg oral
- Q0169Promethazine hcl 12.5mg oral
- Q0173Trimethobenzamide hcl 250mg
- Q0177Hydroxyzine pamoate 25mg
- Q0180Dolasetron mesylate oral
- Q0181Unspecified oral anti-emetic
- Q0224Inj, pemivibart, 4500 mg
- Q0234Inj, tocilizumab-bavi, 1mg
- Q0235Inj, monoclon antibody, 1 mg
- Q0237Inj, tocilizumab-anoh, hospi
- Q0238Inj, tocilizumab-aazg, hospi
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.